Management of Acute Heavy Bleeding
The immediate treatment for acute heavy bleeding should include rapid assessment of bleeding source, hemodynamic stabilization with crystalloids, early administration of tranexamic acid (1g over 10 minutes followed by 1g over 8 hours), and implementation of a balanced transfusion strategy approaching a 1:1:1 ratio (RBC:plasma:platelets) for massive hemorrhage. 1, 2
Initial Assessment and Stabilization
Rapid clinical assessment:
- Evaluate visible blood loss (on clothes, floor, drains)
- Check for signs of internal bleeding
- Assess vital signs (heart rate, blood pressure, capillary refill, skin color, consciousness)
- Look for injury patterns that suggest major bleeding sources 2
Hemodynamic stabilization:
Immediate Interventions
Medications
Tranexamic acid:
Blood product administration:
Procedural Interventions
Source identification:
Bleeding control:
- Direct pressure for external bleeding
- Packing, direct surgical control, and local hemostatic procedures for surgical bleeding 2
- Damage control surgery for severely injured patients with deep hemorrhagic shock 2
- Pelvic ring closure and stabilization for patients with pelvic ring disruption 2
- Angiographic embolization for ongoing instability despite other measures 2
Ongoing Management
Monitoring:
- Regular laboratory assessment: hemoglobin, platelet count, PT, aPTT, fibrinogen levels
- Repeat coagulation tests every 30-60 minutes during active bleeding 1
- Monitor for rebleeding and complications of massive transfusion
Correction of physiologic derangements:
- Actively warm patient to prevent hypothermia
- Correct acidosis
- Monitor and treat hypocalcemia from citrate toxicity during massive transfusion 2
Specific bleeding scenarios:
Common Pitfalls and Caveats
Avoid over-resuscitation with fluids before bleeding is controlled, as this may worsen bleeding through increased blood pressure and dilutional coagulopathy 6
Don't delay tranexamic acid administration - efficacy decreases significantly when given later in the course of bleeding 2
Be aware of contraindications to tranexamic acid including subarachnoid hemorrhage, active intravascular clotting, and history of hypersensitivity 3
Consider underlying bleeding disorders in patients with disproportionate bleeding, especially in cases of heavy menstrual bleeding where up to 20% may have an inherited bleeding disorder 5
Monitor for transfusion-related complications including Transfusion-Related Acute Lung Injury (TRALI), Transfusion-Associated Circulatory Overload (TACO), and metabolic derangements 1
By following this structured approach to acute heavy bleeding, focusing on early identification, rapid intervention with tranexamic acid, balanced blood product administration, and definitive bleeding control, you can significantly improve patient outcomes in terms of morbidity and mortality.